Clinical Trial Update: Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI [NA]

View source ↗

Summary

This entry describes a clinical trial evaluating benralizumab for severe eosinophilic asthma using inhaled hyperpolarized Xenon-129 MRI, with the study currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Eosinophilic Asthma

Drugs mentioned

• FASENRA (BENRALIZUMAB)

Snippet

Sponsor: Dr. Grace Parraga | Conditions: Asthma; Eosinophilic | NA | Status: ACTIVE_NOT_RECRUITING